Dr. Catalona’s national media includes national articles and interviews on prostate cancer treatment and research directed to a non-medical audience and for which Dr. Catalona was a major contributor of information.
A Clinical Dilemma: What Is Normal?
PSA testing is a prominent example of how a “normal” clinical value is derived, accepted, and continuously revised.
Dr. Catalona’s Position: Not Using Cipro
The use of ciprofloxacin (Cipro) as a test to see whether an elevated PSA level will decrease is controversial. His current practice is to prescribe an antibiotic other than Cipro
Prostate Cancer Deaths Decline
More than 90% of all prostate cancers are discovered in the local and regional stages; the 5-year relative survival rate for patients whose tumors are diagnosed at these stages approaches
Two PSA Test Standards Are Causing Problems in Screening for Prostate Cancer
Two PSA test standards are causing serious problems for early detection of prostate cancer. If patients and their doctors are not aware of the differences in tests, early diagnosis and
Active Monitoring Has Its Risk
I am not a fan of active monitoring or watchful waiting in what are being called low-risk prostate cancer (CaP) patients.
This article reports on a study that addresses the question: Do the 3 significant 8q24 prostate cancer susceptibility regions predict aggressive disease?
Genetics of Prostate Cancer: What You Should Know; Why You Should Care
This article continues our coverage on new discoveries in the genetics of prostate cancer that continue to change the way researchers view the development of prostate cancer and on the
Hormonal Therapy Explained
Recent studies have provided new information and new practices for the use of Hormonal Therapy in the treatment of prostate cancer. Dr. Catalona updates his previous writing on this topic.
Alleles: Secrets to Cancer Risk
A new model for studying the genetics of cancer is replacing the traditional perspective f studying one gene carried through generations of a family. Now, researchers are looking at several
Answers to Common Questions About PSA Testing
Should Screening for Prostate Cancer Begin Before 50? Should a PSA Below 4 Trigger a Biopsy? Should Men 70-75 Be Screened for Prostate Cancer?
